Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0ZU4U
|
|||
| Former ID |
DIB015684
|
|||
| Drug Name |
MLR-1023
|
|||
| Synonyms |
Oral kinase activator (theraTRACE, oral, type 2 diabetes), Melior
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Obesity [ICD-11: 5B81; ICD-10: E66; ICD-9: 278] | Phase 2 | [1] | |
| Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Phase 2 | [2] | ||
| Company |
Melior Pharmaceuticals Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H10N2O2
|
|||
| Canonical SMILES |
CC1=CC(=CC=C1)OC2=CNC(=O)N=C2
|
|||
| InChI |
1S/C11H10N2O2/c1-8-3-2-4-9(5-8)15-10-6-12-11(14)13-7-10/h2-7H,1H3,(H,12,13,14)
|
|||
| InChIKey |
HJQILFPVRNHTIG-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 41964-07-2
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
455866, 5682495, 8175858, 15340587, 22395661, 34705018, 47207840, 52277639, 88532767, 103166817, 104330802, 104830576, 125824962, 128070444, 135001384, 137137373, 140986571, 162224227, 164041578, 172919737, 176246057, 179150466, 185967100, 198952755, 223579133, 226937214, 251960715, 252158189, 252160589, 252450098, 252543539
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02317796) Adult Subjects With Uncontrolled Type 2 Diabetes. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.